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a b s t r a c t
A 76-year-old female was implanted with a cardiac resynchronization therapy (CRT) device, with the left
ventricular lead implanted through a transvenous approach. One day after implantation, diaphragmatic
stimulation was observed when the patient was in the seated position, which could not be resolved by
device reprogramming. We performed thoracoscopic phrenic nerve insulation using a Gore-Tex patch.
The left phrenic nerve was carefully detached from the pericardial adipose tissue, and a Gore-Tex patch
was inserted between the phrenic nerve and pericardium using a thoracoscopic technique. This approach
represents a potential option for the management of uncontrollable phrenic nerve stimulation
during CRT.
& 2013 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
A patient with phrenic nerve stimulation during cardiac resyn-
chronization therapy (CRT) was successfully treated with thoraco-
scopic phrenic nerve insulation. Thoracoscopic phrenic nerve
insulation using a Gore-Tex patch is an effective and less invasive
alternative to surgical left ventricular (LV) lead insertion for the
management of uncontrollable phrenic nerve stimulation during
CRT.
2. Case report
A 76-year-old female with New York Heart Association class III
congestive heart failure was referred to our hospital for cardiac
resynchronization therapy (CRT). Echocardiography showed severe
LV dysfunction (LV ejection fraction¼23%, LV end-diastolic diame-
ter¼69 mm, LV end-systolic diameter¼59 mm, and LV end-systolic
volume¼124 mL) and signiﬁcant LV dyssynchrony. A 12-lead
ECG showed sinus rhythm and complete left bundle block with a
QRS duration of 184 ms (Fig. 1A). Coronary angiography showed
no signiﬁcant stenosis, and we diagnosed her as having dilated
cardiomyopathy. Holter ECG monitoring detected non-sustained
ventricular tachycardia.
The patient was scheduled for implantation of a deﬁbrillator with
biventricular pacing capability (CRT-D). A transvenous approach was
utilized to position an active-ﬁxation lead (1888TC, 52 cm, St. Jude
Medical, St. Paul, MN, USA) in the right atrial appendage and a right
ventricular shocking lead (DURATA 7122Q, St. Jude Medical, St. Paul,
MN, USA) in the lower septum of the right ventricle (Fig. 2C and D).
The LV lead (QuickFlex 1158T-86 cm, St. Jude Medical, St. Paul, MN,
USA) was introduced via the right subclavian vein and advanced
through the coronary sinus into the posterolateral vein (Fig. 2B–D).
A coronary sinus angiogram revealed that the lateral vein was too
small (Fig. 2A), and the LV lead could not be inserted. We inserted
the LV lead into the posterolateral vein (Fig. 2B). The LV pacing
threshold at implantation was 0.7 V at 0.4 ms, and the impedance
was 1174 Ω. The R-wave sensing threshold was 22.9 mV. Diaphragm
stimulation was not observed on ﬂuoroscopy during pacing at
outputs of up to 10 V. A CRT-D generator (PROMOTEþCD3211-
36Q, St. Jude Medical, St. Paul, MN, USA) was implanted in the left
pectoral region.
One day after implantation, diaphragmatic stimulation was
observed when the patient was in the seated position, and it
could not be resolved by reprogramming the device. We decided
to replace the LV lead; however, there were no other vein branches
suitable for CRT in the lateral region of the LV (Fig. 2A and B). We
tried to insert the lead into an upper branch of the posterolateral
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vein, but we could not obtain a suitable pacing threshold. We
replaced the LV lead more proximally in the same posterolateral
vein, and conﬁrmed that diaphragm stimulation was not observed
on ﬂuoroscopy during pacing at outputs of up to 10 V. A post-
operative 12-lead ECG showed a QRS duration of 128 ms during
biventricular pacing (Fig. 1B).
However, diaphragmatic twitching appeared again with the
patient in the seated position and could not be resolved by device
reprogramming. We did not replace the LV lead because of the
increased risk of infection associated with a third operation.
Therefore, the patient was scheduled to undergo a thoracoscopic
LV lead insulation using the Gore-Tex patch.
The operation was performed under general anesthesia. A
thoracoscopic procedure was carried out with a 3-port technique:
1 camera port (11.5 mm) was placed in the eighth intercostal space
at the mid-axillary line, and 2 working ports (5 mm each) were
placed in the ﬁfth intercostal space at the anterior and posterior
axillary lines. The left phrenic nerve was carefully detached from
pericardial adipose tissue (Fig. 3A), and electrical insulation was
accomplished with a 45 cm2 Gore-Tex patch inserted between
the phrenic nerve and the pericardium (Fig. 3B). The operative
time was 112 min and total blood loss was 3 mL. No intraoperative
or postoperative complications were observed. Following the
procedure, the LV pacing threshold was 1.8 V at 0.4 ms and the
impedance was 674 Ω. The R-wave sensing threshold was 30.0 mV.
Diaphragm stimulation was not observed in any position during
pacing at outputs of up to 10 V.
3. Discussion
The present case report describes a patient who underwent
successful thoracoscopic LV lead insulation to eliminate phrenic
nerve stimulation during CRT. An echocardiography conducted at
2 years after implantation showed signiﬁcant reverse remodeling
(LV ejection fraction¼48.9%, LV end-diastolic diameter¼50 mm,
LV end-systolic diameter¼35 mm, and LV end-systolic volume¼
55.8 mL). CRT has been demonstrated to improve systolic function
in heart failure patients with conduction system disorders [1,2].
The stimulation site within the LV might play an important role in
the outcome of CRT [3,4]. Transvenous LV lead implantation
depends on the coronary venous anatomy. Coronary sinus angio-
graphy revealed that there were no other branches suitable
for CRT (Fig. 2B). Lead insertion in the anterior or mid-cardiac
vein may not result in optimal LV synchronization [5–7]. Further-
more, repeated implantation procedures are associated with an
increased risk of device infection. Therefore, we decided not to
perform LV lead replacement using a coronary vein-based lead
system [8].
An epicardial LV lead implanted surgically was an option for the
elimination of phrenic nerve simulation [9,10]. The surgical LV lead
implantation could be performed using a thoracoscopic approach.
Even though the epicardial side of the surgically implanted
epicardial lead was insulated, in rare instances, this might cause
phrenic nerve stimulation [11]. In most cases, a suitable site away
from the phrenic nerve can be found. However, in CRT, the suitable
area was limited to the mid-lateral region of the LV, and CRT with
an epicardial lead implanted at the mid-lateral region of the LV can
potentially result in a recurrence of phrenic nerve twitching [11].
Furthermore, the surgically implanted LV lead has to be connected
with a subcutaneous CRT-D generator. In our case, a 12-lead ECG
during biventricular pacing showed a narrow QRS width, and
except for the phrenic nerve stimulation, the implanted lead
position was appropriate for LV synchronization. We considered
that the thoracoscopic placement of Gore-Tex insulation on the
transvenous lead was a less invasive option than surgical LV lead
implantation.
In our case, diaphragmatic twitching was only observed in the
seated position, but not in the supine position. This problem could
not be identiﬁed during the implant procedure. Recently, a
quadripolar LV pacing lead that features 4 pacing electrodes (St.
Jude Medical, St. Paul, MN, USA) has become available. This may
provide more options to minimize implant complications such as
diaphragmatic stimulation.
Injury to the phrenic nerve and phrenic nerve paralysis are
considerable potential complications of phrenic nerve electrical
Fig. 1. (A) The 12-lead ECG at admission. The 12-lead ECG showed sinus rhythm and
complete left bundle block with a QRS duration of 184 ms (10 mm/mV, 25 mm/s).
(B) The 12-lead ECG during CRT. The postoperative 12-lead ECG showed a QRS
duration of 128 ms during biventricular pacing. CRT, cardiac resynchronization
therapy.
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insulation. Furthermore, thoracoscopic phrenic nerve insulation
requires general anesthesia, the risks of which should also be
considered. We believe that replacement of the LV lead using a
transvenous approach is the method of choice for the avoidance of
phrenic nerve stimulation. However, when acceptable results
cannot be obtained using the transvenous approach, as in our
Fig. 2. (A) Small lateral vein. Contrast injection from the guiding catheter in the CS revealed that the lateral vein was too small to insert the lead. Indeed, we tried but we
could not insert the lead deep enough. (B) Selective angiogram of the posterolateral vein. Selective angiography of the posterolateral vein revealed that this vein was suitable
for LV lead implantation. (C) The LV lead position is shown in the right anterior oblique (RAO) view. (D) The LV lead position is shown in the left anterior oblique (LAO) view.
CS: coronary sinus. LV: left ventricle.
Fig. 3. (A) The left phrenic nerve was carefully detached from adipose tissues around the pericardium. The black arrow indicates the detached phrenic nerve. (B) Electrical
insulation was accomplished by the insertion of a 45 cm2 Gore-Tex patch between the phrenic nerve and the pericardium. The black arrow indicates the detached
phrenic nerve.
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case, thoracoscopic phrenic nerve insulation represents a potential
option for the management of uncontrollable phrenic nerve
stimulation during CRT [12].
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